Posts tagged “Biotech & Life Science”
Elan will receive 21 percent of the royalties earned by Theravance from GlaxoSmithKline on the four respiratory medicines, and 20 percent of that income stream will be paid to Elan shareholders as a dividend.
Scientific research has revealed many things but science is still keeping some secrets from David Murdock. The billionaire businessman founded and funded the David H. Murdock Research Institute to search for answers. And now he's putting up $50 million more in his continuing quest.
Medicago developed its H7N9 flu vaccine candide using its proprietary technology that produces vaccines from the leaves of tobacco plants.
Chairman and co-founder Dr. Dennis Gillings joins his company's executive management team for the ringing of the opening bell on the NYSE on Friday. Quintiles executed the biggest IPO in Triangle history on Thursday.
Dennis Gillings, who started Quintiles in a trailer more than 30 years ago, rings the opening bell on the New York Stock Exchange today to celebrate the giant's return to public markets. Stephen Wiehe, who led SciQuest through a similar private-to-public Odyssey, recalls the "humbling" ringing bell honor.
Cornerstone Therapeutics acquires a drug to treat a consequence of cystic fibrosis and has a new drug coming to market. To boost sales, Cornerstone's CEO says the company will be hiring more sales people. WRALTechWire Insiders get the details.
"This is the tipping point for Innovation Quarter," says John McConnell, chief executive officer at Wake Forest Baptist Medical Center. "As a result of this unique public-partnership the city, county and region will all benefit significantly."
Following Quintiles initial public stock offering, Chief Operating Officer John Ratliff gave WRAL Tech Wire an interview from the New York Stock Exchange. Read what he has to say about the now public company.
A startup in Chapel Hill is hoping the JOBS Act bill passed in 2012 will help ease its way at lower costs into public markets. The firm recently raised $5 million as well. WRALInsiders can get the details.
Two drug giants with substantial operations in North Carolina are drastically cutting the costs of their cervical cancer vaccines as part of the first large-scale effort to get the shots to girls in the world's poorest areas.
Shares in the world's largest life science services company are expected to begin trading Thursday on the New York Stock Exchange with an opening price of $40.
David H. Murdock gives $50 million to the research institute that bears his name in Kannapolis. He says he wants to do "all I can to advance scientific research that will vastly improve the quality of life for mankind."